申请人:ABBOTT LAB
                            
                            
                                公开号:WO2011079105A1
                            
                            
                                公开(公告)日:2011-06-30
                            
                            The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.